GB202106029D0 - therapeutic use of antibody - Google Patents

therapeutic use of antibody

Info

Publication number
GB202106029D0
GB202106029D0 GBGB2106029.8A GB202106029A GB202106029D0 GB 202106029 D0 GB202106029 D0 GB 202106029D0 GB 202106029 A GB202106029 A GB 202106029A GB 202106029 D0 GB202106029 D0 GB 202106029D0
Authority
GB
United Kingdom
Prior art keywords
antibody
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2106029.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncobiopharm Ltd
Original Assignee
Oncobiopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncobiopharm Ltd filed Critical Oncobiopharm Ltd
Priority to GBGB2106029.8A priority Critical patent/GB202106029D0/en
Publication of GB202106029D0 publication Critical patent/GB202106029D0/en
Ceased legal-status Critical Current

Links

GBGB2106029.8A 2021-04-28 2021-04-28 therapeutic use of antibody Ceased GB202106029D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2106029.8A GB202106029D0 (en) 2021-04-28 2021-04-28 therapeutic use of antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2106029.8A GB202106029D0 (en) 2021-04-28 2021-04-28 therapeutic use of antibody

Publications (1)

Publication Number Publication Date
GB202106029D0 true GB202106029D0 (en) 2021-06-09

Family

ID=76193602

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2106029.8A Ceased GB202106029D0 (en) 2021-04-28 2021-04-28 therapeutic use of antibody

Country Status (1)

Country Link
GB (1) GB202106029D0 (en)

Similar Documents

Publication Publication Date Title
IL292810A (en) Therapeutic compounds and methods of use
EP4067377A4 (en) Development and application of therapeutic agents for tslp-related diseases
IL287282A (en) Anti-mertk antibodies and their methods of use
ZA202006264B (en) Stable formulations of therapeutic antibody
IL277338A (en) Use of antibody drug conjugates comprising tubulin disrupting agents to treat solid tumor
IL292657A (en) Therapeutic derivatives of interleukin-22
GB202012331D0 (en) Therapeutic antibodies
IL289787A (en) Antibody combinations for treatment of cancer in specific patients
IL285134A (en) Therapeutic antibody formulation
GB202020573D0 (en) Novel methods of therapy
IL297268A (en) Therapeutic use of pleuromutilins
IL288886A (en) Antibodies and methods of use
GB202020572D0 (en) Novel methods of therapy
GB202106029D0 (en) therapeutic use of antibody
GB201805100D0 (en) Treatment of sarcopenic diseases
GB202216204D0 (en) Therapeutic use of antibody
GB202206189D0 (en) Therapeutic use of antibody
GB202019475D0 (en) Therapeutic compounds and their use
EP3890742A4 (en) Prodrugs of anti-cancer and anti-autoimmune diseases therapeutic agents, and methods of making and use thereof
GB201918541D0 (en) Therapeutic compounds and their use
GB201812861D0 (en) Methods of administering therapy
GB202108677D0 (en) Therapeutic antibodies
GB201903012D0 (en) Antibodies for treatment of cancer and other diseases
IL309664A (en) Administration of anti-hpa-1a antibodies
GB202311497D0 (en) Therapeutic antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)